ANI Pharmaceuticals, Inc.

ANIPNASDAQHealthcareDrug Manufacturers - Specialty & Generic

$72.61- (-)1Y −22.29%

As of Oct 23, 2026 close

Market cap: $1.59B
P/E (TTM): 15.04
Forward P/E: -
Dividend yield: -
52-week range: $69.58$97.00
Volume (live): -
Avg. volume (3M): 401.67K

ANI Pharmaceuticals, Inc. (ANIP) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for ANI Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Buy

Based on 10 unique analysts

(12 total ratings in last 90 days)

High Confidence3.0:1 Buy/Sell

Average Price Target

$106.75

+47.02% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest ANIP Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 22, 2026	Ekaterina Knyazkova	JP Morgan	Maintains	Buy	$115.00
Oct 6, 2026	Vamil Divan	Guggenheim	Reiterates	Buy	$119.00
Sep 23, 2026	Les Sulewski	Oppenheimer	Initiates	Hold	$85.00
Sep 21, 2026	Brandon Folkes	HC Wainwright	Maintains	Buy	$121.00
Sep 9, 2026	Daniel Clark	Leerink Partners	Initiates	Buy	$104.00
Aug 26, 2026	Glen Santangelo	Barclays	Maintains	Buy	$100.00
Aug 14, 2026	Sundeep Ganoria	Zacks Equity Research	Initiates Coverage	Sell	-
Aug 10, 2026	Gary Nachman	Canaccord Genuity	Maintains	Hold	$91.00 → $90.00 −1.00 (−1.1%)
Aug 10, 2026	Unknown Analyst	Jefferies	Reiterates	Buy	$120.00
Aug 10, 2026	Ekaterina Knyazkova	JP Morgan	Reiterates	Buy	$115.00
Aug 7, 2026	Vamil Divan	Guggenheim	Reiterates	Buy	$124.00 → $119.00 −5.00 (−4.0%)
Aug 7, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Sell	-

Ekaterina Knyazkova

JP Morgan

BuyMaintains

$115.00

Oct 22

Vamil Divan

Guggenheim

BuyReiterates

$119.00

Oct 6

Les Sulewski

Oppenheimer

HoldInitiates

$85.00

Sep 23

Brandon Folkes

HC Wainwright

BuyMaintains

$121.00

Sep 21

Daniel Clark

Leerink Partners

BuyInitiates

$104.00

Sep 9

Glen Santangelo

Barclays

BuyMaintains

$100.00

Aug 26

Sundeep Ganoria

Zacks Equity Research

SellInitiates Coverage

Aug 14

Gary Nachman

Canaccord Genuity

HoldMaintains

$91.00 → $90.00

Aug 10

Unknown Analyst

Jefferies

BuyReiterates

$120.00

Aug 10

Ekaterina Knyazkova

JP Morgan

BuyReiterates

$115.00

Aug 10

Vamil Divan

Guggenheim

BuyReiterates

$124.00 → $119.00

Aug 7

Zacks Equity Research

SellInitiates Coverage

Aug 7

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 22, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for ANIP?

The analyst consensus rating for ANIP is Buy, based on the latest ratings from 10 analysts over the last 90 days.

What is the average price target for ANIP?

The average 12-month price target for ANIP is $106.75, representing an upside of 47.0% from the Oct 23, 2026 close of $72.61.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.